EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
91 hedge funds and large institutions have $291M invested in Eiger BioPharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
11% less funds holding
Funds holding: 102 → 91 (-11)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
91
Holding in Top 10
5
Calls
$4.16M
Puts
$2.28M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$3.24M | |
| 3 | +$3.1M | |
| 4 |
Millennium Management
New York
|
+$1.89M |
| 5 |
BlackRock
New York
|
+$1.59M |
Top Sellers
| 1 | -$8.89M | |
| 2 | -$3.52M | |
| 3 | -$2.77M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.04M |
| 5 |
CCM
Copernicus Capital Management
San Francisco,
California
|
-$1.94M |